Advanced biotechnology is at the heart of the next industrial revolution. Here's why we invest in this future.
Biotechnologies are radically transforming how we treat diseases, produce energy and develop new materials.
The BioHighTech sector represents the convergence of life sciences, engineering and digital technologies. From personalised medicine to advanced diagnostics, from gene therapies to smart medical devices, biotechnologies are driving 21st-century healthcare innovation.
Europe — and Italy in particular, with its research ecosystem and fabric of innovative SMEs — plays a key role in this transformation. The Friuli Venezia Giulia region, with its concentration of research centres and universities, provides fertile ground for the development of high-potential BioHighTech companies.
The global biotechnology market exceeds $1.5 trillion and grows at an annual rate above 12%. The demand for innovative healthcare solutions shows no signs of slowing down.
Scientific discoveries from recent decades are reaching commercial maturity. Technologies such as genomic sequencing, cell therapies and biosensors are moving from laboratories to daily clinical practice.
Investing in BioHighTech means concretely contributing to improving public health, environmental sustainability and the competitiveness of the European production system.
The biotech sector has historically generated returns above market indices, thanks to the high value of intellectual property and technological barriers to entry.
The demand for healthcare innovation is structural and independent of economic cycles. Population ageing and growing health awareness guarantee constant demand.
The integration of biotech, artificial intelligence, nanotechnologies and big data opens unprecedented innovation scenarios, multiplying value creation opportunities.
The European Union and national governments allocate growing resources to biomedical research and innovative companies in the sector, with dedicated funds and tax incentives.
Biovalley Group leads the BioHighTech-NET network, a collaboration agreement between companies to develop shared projects and increase innovative capacity and competitiveness in international markets.
In 2020, BioHighTechNet 4.0 was established as an independent legal entity.
Discover BioHighTech-NETDo you have an innovative project in the BioHighTech sector? Biovalley Group is always looking for companies with strong growth potential.